Indiana Medicaid sets prior approval requirement to dispense brands with generic equivalents.
INDIANA MEDICAID BRAND NAME DRUG PRIOR AUTHORIZATION REQUIRED under a state regulation announced in March. Except for products with narrow therapeutic ranges, physicians will be required to obtain prior authorization to prescribe a brand name drug if a generic equivalent is available. The Indiana Medicaid office calculated that $4.7 mil. could be saved in fiscal 1997 (beginning July 1) by the state and federal governments if unnecessary prescribing of brands is controlled.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth